Mucormycosis and COVID-19: An intersecting crisis

ABSTRACT

There has been an increasing propensity of opportunistic fungal infections such as mucormycosis occurring in COVID-19 patients. It is imperative that we are aware of clinical presentation, rate of spread of mucormycosis and prescribes medications such as corticosteroids judiciously, especially in severely ill patients, and uncontrolled diabetics with ketoacidosis. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.